Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
BG Medicine
(OTCEM:BGMD)
Intraday
$~0
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$~0
0
[0.00%]
At close: Dec 6
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for BG Medicine Stock (OTC:BGMD)
BG Medicine Stock (OTC: BGMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 25, 2019
Stocks That Hit 52-Week Lows On Monday
Lisa Levin
-
Nov 25, 2019, 11:15AM
Wednesday, December 23, 2015
BG Medicine Reports Withdrawl of 510(k) Premarket Notification for Proposed Added Indication for BGM Galectin-3 Test
Benzinga
-
Dec 23, 2015, 7:51AM
Friday, August 14, 2015
BG Medicines Reports Q2 Loss of $0.23/Share, Sales $505K
Benzinga
-
Aug 14, 2015, 4:44PM
Thursday, August 13, 2015
Mid-Day Market Update: Thursday's Movers, China, Tesla And More
Benzinga
-
Aug 13, 2015, 1:09PM
Stocks Hitting 52-Week Lows
Benzinga
-
Aug 13, 2015, 10:22AM
Morning Market Losers
Benzinga
-
Aug 13, 2015, 9:54AM
BG Medicine Prices 2.315M Unit Offering At $1/Unit, Prices 184K Series B Units At $1/Share
Benzinga
-
Aug 13, 2015, 8:36AM
Wednesday, August 12, 2015
BG Medicine Announces Proposed Offering of Stock
Benzinga
-
Aug 12, 2015, 4:30PM
Wednesday, July 08, 2015
BG Medicine Announces One-for-Four Reverse Stock Split
Benzinga
-
Jul 8, 2015, 5:00PM
Monday, July 06, 2015
First Automated Test for Galectin-3 Now Available in U.S.
Benzinga
-
Jul 6, 2015, 8:01AM
Tuesday, May 19, 2015
BG Medicine Files $75 Mixed Shelf Accordign to S-3
Benzinga
-
May 19, 2015, 4:46PM
Thursday, May 14, 2015
BG Medicine Q1 EPS -$0.04 vs -$0.03 est, Revenue 0.44M vs 1.6M est
Benzinga
-
May 14, 2015, 7:45AM
Tuesday, March 31, 2015
BG Medicine Issues Submission of 510(k) to FDA Related to Added Indication for BGM Galectin-3(R)
Benzinga
-
Mar 31, 2015, 7:16AM
Earnings Scheduled For March 31, 2015
Benzinga
-
Mar 31, 2015, 4:15AM
Thursday, March 26, 2015
BG Medicine Welcomes Major Publication on BioImage Study in Journal of the American College of Cardiology
Benzinga
-
Mar 26, 2015, 7:32AM
Monday, February 02, 2015
BG Medicine Receives Favorable NASDAQ Listing Determination
Benzinga
-
Feb 2, 2015, 7:11AM
Tuesday, December 30, 2014
BG Medicine Announces FDA Made Publicly Available the 510(k) Clearance for Premarket Notification Number K140436, The First Automated Version of Galectin-3 Testing to Receive Regulatory Clearance in US -8-K
Benzinga
-
Dec 30, 2014, 9:28AM
Thursday, November 13, 2014
Ladenburg Thalmann Downgrades BG Medicine, Inc. to Neutral
Benzinga
-
Nov 13, 2014, 11:04AM
BG Medicine, Inc. Reports Q3 EPS of $(0.07), Inline; Revenue of $695.0K vs $800.0K Est
Benzinga
-
Nov 13, 2014, 6:32AM
Thursday, September 11, 2014
8-K from BG Medicine Shows Co. Implemented (on Sept. 11th) Reduction of ~55% of Workforce (12 Employees); Sees ~$300K One-Time Related Charge
Benzinga
-
Sep 11, 2014, 5:22PM
Thursday, August 14, 2014
BG Medicine, Inc. Reports Q2 EPS of $(0.06), Inline
Benzinga
-
Aug 14, 2014, 8:06AM
Earnings Scheduled For August 14, 2014
Benzinga
-
Aug 14, 2014, 5:56AM
Wednesday, July 16, 2014
Filing from BG Medicine Shows Registration for 4.11M Share Offering Through Selling Holders
Benzinga
-
Jul 16, 2014, 4:39PM
Monday, June 23, 2014
Healthways, Genesis Physicians Group Unite to Enhance Healthcare - Analyst Blog
Benzinga
-
Jun 23, 2014, 8:41AM
Thursday, June 19, 2014
PAREXEL's ClinPhone RTSM Cuts Clinical Trial Start-Up Time - Analyst Blog
Benzinga
-
Jun 19, 2014, 8:07AM
Tuesday, May 20, 2014
Covance Expands in Market Access - Analyst Blog
Benzinga
-
May 20, 2014, 6:20PM
Monday, May 19, 2014
MedAssets Down to Sell - Analyst Blog
Benzinga
-
May 19, 2014, 3:50PM
Wednesday, May 14, 2014
Morning Market Losers
Benzinga
-
May 14, 2014, 10:04AM
BG Medicine, Inc. Reports Q1 EPS of $(0.08); Revenue of $739.0K
Benzinga
-
May 14, 2014, 7:31AM
Earnings Scheduled For May 14, 2014
Benzinga
-
May 14, 2014, 5:37AM
Thursday, May 08, 2014
Covance Posts In-line Q1 Earnings; Falls on Trimmed View - Analyst Blog
Benzinga
-
May 8, 2014, 4:11PM
Wednesday, April 30, 2014
PAREXEL Q3 Earnings & Revs Beat Ests - Analyst Blog
Benzinga
-
Apr 30, 2014, 4:01PM
Monday, April 28, 2014
Healthways Up on Narrower-than-Expected Q1 Loss - Analyst Blog
Benzinga
-
Apr 28, 2014, 8:51AM
Friday, April 25, 2014
IPC The Hospitalist (IPCM) in Focus: Stock Slumps 12.2% - Tale of the Tape
Benzinga
-
Apr 25, 2014, 9:31AM
Tuesday, April 22, 2014
DaVita Expands, Strengthens Florida Presence - Analyst Blog
Benzinga
-
Apr 22, 2014, 7:22PM
Wednesday, April 16, 2014
Sub $5 Stocks With Expected Return Of Over 50% In 2014: Investment Idea Of The Day
Benzinga
-
Apr 16, 2014, 3:42PM
Thursday, April 03, 2014
Morning Market Losers
Benzinga
-
Apr 3, 2014, 9:49AM
BG Medicine Prices ~6.452M Shares at $1.55/Share for Net Proceeds ~$8.9M
Benzinga
-
Apr 3, 2014, 9:17AM
Wednesday, April 02, 2014
BG Medicine Announces Proposed Public Offering of Common Stock
Benzinga
-
Apr 2, 2014, 4:07PM
Tuesday, March 25, 2014
Morning Market Movers
Benzinga
-
Mar 25, 2014, 9:39AM
Thursday, March 20, 2014
Morning Market Movers
Benzinga
-
Mar 20, 2014, 9:39AM
BG Medicine Reports Issuance of Patent Covering Galectin-3
Benzinga
-
Mar 20, 2014, 8:01AM
BG Medicine, Inc. Reports Q4 EPS of $(0.06) vs $(0.12) Est
Benzinga
-
Mar 20, 2014, 7:54AM
Earnings Scheduled For March 20, 2014
Benzinga
-
Mar 20, 2014, 5:12AM
Monday, February 24, 2014
BG Medicine Shares Move Higher; May be Attributed to Positive Roberto Pedone Comment
Benzinga
-
Feb 24, 2014, 2:26PM
Monday, January 27, 2014
BG Medicine to Transfer to NASDAQ Capital Market
Benzinga
-
Jan 27, 2014, 8:30AM
Monday, January 06, 2014
Morning Market Losers
Benzinga
-
Jan 6, 2014, 10:02AM
Friday, January 03, 2014
Morning Market Movers
Benzinga
-
Jan 3, 2014, 10:04AM
Wednesday, December 11, 2013
Morning Market Movers
Benzinga
-
Dec 11, 2013, 9:56AM
Wednesday, November 06, 2013
BG Medicine, Inc. Reports Q3 EPS of $(0.13) vs $(0.17) Est
Benzinga
-
Nov 6, 2013, 7:35AM
Show more